Indian drugmaker Cipla forms JV with Biopharma SPA in Algeria

Visual from Cipla website

Indian drugmaker Cipla Ltd has entered into an agreement with Biopharma SPA for establishing a joint venture (JV) company in Algeria to manufacture and market respiratory products.

“Cipla (EU) Ltd, a wholly-owned subsidiary of the company has entered into a definitive agreement with Biopharma SPA for establishing a joint venture company in Algeria,” Cipla said in a BSE filing on Wednesday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter